Answer
Yes, Pemazyre (pemigatinib) is contraindicated in people with hypersensitivity to pemigatinib or any of its excipients listed in section 6.1 of the product information.
Sources for this answer
- Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked